Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry

被引:0
作者
Kerstin Hellwig
Yvonne Geissbuehler
Meritxell Sabidó
Catrinel Popescu
Alessandra Adamo
Joachim Klinger
Asher Ornoy
Peter Huppke
机构
[1] Ruhr University,Department of Neurology, St. Joseph and St. Elisabeth Hospital
[2] Novartis Pharma AG,Global Medical Affairs
[3] Research and Development,Safety Surveillance and Aggregate Reports
[4] Global Epidemiology,Global Safety
[5] Biogen Idec Ltd,Biometrics
[6] Bayer AG,Department of Medical Neurobiology
[7] Synteract GmbH,Department of Pediatrics and Pediatric Neurology
[8] Hebrew University of Jerusalem,undefined
[9] University Medical Center,undefined
来源
Journal of Neurology | 2020年 / 267卷
关键词
Multiple sclerosis; Interferon-beta; Disease-modifying drugs; Pregnancy; Congenital anomalies; Spontaneous abortions;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1715 / 1723
页数:8
相关论文
共 98 条
[1]  
Vaughn C(2018)An update on the use of disease-modifying therapy in pregnant patients with multiple sclerosis CNS Drugs 32 161-178
[2]  
Bushra A(2018)ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis Eur J Neurol 25 215-237
[3]  
Kolb C(2018)ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis Mult Scler 24 96-120
[4]  
Weinstock-Guttman B(2019)UK consensus on pregnancy in multiple sclerosis: ‘Association of British Neurologists’ guidelines Pract Neurol 79 1130-1135
[5]  
Montalban X(2012)Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review Neurology 22 801-809
[6]  
Gold R(2016)Interferon-beta exposure during first trimester is safe in women with multiple sclerosis—a prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry Mult Scler 255 1250-1253
[7]  
Thompson AJ(2008)Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis? J Neurol 75 1794-1802
[8]  
Otero-Romero S(2010)Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis Neurology 2016 1034912-534
[9]  
Amato MP(2016)Pregnancy and the use of disease-modifying therapies in patients with multiple sclerosis: benefits versus risks Mult Scler Int 16 523-253
[10]  
Chandraratna D(2017)Treatment of multiple sclerosis during pregnancy—safety considerations Expert Opin Drug Saf 4 e004536-589